Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii
Int J Clin Oncol. 2023 Mar 24. doi: 10.1007/s10147-023-02326-w. Online ahead of print.ABSTRACTProf. Setsuro Fujii achieved significant results in the field of drug discovery research in Japan. He developed nine well-known drugs: FT, UFT, S-1 and FTD/TPI are anticancer drugs, while cetraxate hydrochloride, camostat mesilate, nafamostat mesilate, gabexate mesilate and pravastatin sodium are therapeutic drugs for various other diseases. He delivered hope to patients with various diseases across the world to improve their condition. Even now, drug discovery research based on Dr. Fujii's ideas is continuing.PMID:36961615 | DOI:10.1007/s10147-023-02326-w
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Yoshihiko Maehara Eiji Oki Mitsuhiko Ota Norifumi Harimoto Koji Ando Ryota Nakanishi Tetsuro Kawazoe Yoshiaki Fujimoto Kentaro Nonaka Hiroyuki Kitao Makoto Iimori Kunio Makino Teiji Takechi Takeshi Sagara Kazutaka Miyadera Kazuaki Matsuoka Hiroshi Tsukiha Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Japan Health | Pravastatin | Sodium | Statin Therapy